The Antiarrhythmic Efficacy of Intravenous Therapy with Disopyramide Phosphate
- 1 May 1977
- Vol. 71 (5), 597-606
- https://doi.org/10.1378/chest.71.5.597
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTIONThe Lancet, 1976
- Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.Circulation Research, 1975
- Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphateThe American Journal of Cardiology, 1975
- Disopyramide phosphate: Clinical efficacy of a new oral antiarrhythmie drugClinical Pharmacology & Therapeutics, 1974
- Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversionClinical Pharmacology & Therapeutics, 1974
- Electrophysiological evaluation of disopyramide in manAmerican Heart Journal, 1973
- Effects of Disopyramide on Electrophysiological and Mechanical Properties of the HeartJournal of Pharmaceutical Sciences, 1973
- Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphateAmerican Heart Journal, 1972
- Differential effects of quinidine and diphenylhydantoin on the monophasic action potential of the isolated rabbit heartLife Sciences, 1969
- A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINEBritish Journal of Pharmacology and Chemotherapy, 1963